Data completeness is often monitored by looking at how quickly data arrive after an event, because data that haven’t shown up by a fixed reporting cut-off are effectively incomplete. If there’s a long or highly variable lag between when a case occurs and when its record appears in the dataset, that signals missing data at that point in time, so lag-time measurements serve as a practical indicator of completeness. While independently identifying cases helps ensure broad coverage, it doesn’t by itself quantify how complete the collected data fields are. Quality control does include checks for completeness, but timeliness alone isn’t the same as completeness, and lag-time trends integrate the effect of delayed or missing submissions. So using lag-time reports to gauge whether the dataset is complete at a given point in time is the most informative approach among the options.

This item tests how ICD-10 and ICD-O-3 are used in cancer data. ICD-10 is the general coding system used to record diagnoses and causes of death on death certificates and medical records, covering a wide range of diseases, including cancer. ICD-O-3, on the other hand, is a specialized oncology coding system used primarily by cancer registries to classify tumors by site and morphology, not for coding all diseases. Because one system serves broad mortality and morbidity coding and the other provides detailed tumor-specific coding, the statement that ICD-10 is used for mortality and ICD-O-3 for neoplasms is true. The other options are inaccurate because ICD-10 does more than just mortality, ICD-O-3 is not for all diseases, and the coding formats differ in structure rather than simply being a fixed 5- or 6-digit scheme.

The cell type is defined by the morphology component. In ICD-O, morphology codes specify the histologic type of the tumor—what kind of cancer cells are involved, such as adenocarcinoma, squamous cell carcinoma, lymphoma, and so on. Topography, on the other hand, tells you where the tumor started in the body (the site). Behavior indicates whether the tumor is malignant, in situ, or benign, and is attached to the code as the behavior digit after the slash. Grade reflects how differentiated the cells are, but it does not describe the cell type itself. So the morphology part is the one that indicates the actual cell type. For example, a morphology code identifies the histologic type, while the site is given by topography and the malignant nature by behavior.

When merging records from multiple sources, you need clear rules to pick a single, consistent value so the consolidated record is reliable. Hierarchy rules set a source priority: you take the value from the most trusted source when there’s a conflict, which helps preserve data quality by favoring a known good origin. Most frequent resolves disagreements by selecting the value that appears most often across sources, operating on the idea that convergence across sources implies greater reliability. Known over unknown prioritizes actual, observed data over missing or unknown values, so you don’t throw away information just because one source didn’t have a value. Using these three approaches together covers priority, consensus, and data presence, giving a robust framework for consolidation. That’s why the set of rules includes all of these methods. In practice, you might apply them selectively based on specific data characteristics, but together they form a comprehensive approach to reconciling conflicting records.

HTML lays out what appears on the page and its content, but it has no programming logic to change that content after the page loads. Pure HTML displays the same thing each time unless something else runs to alter it. Dynamic behavior comes from scripting (like JavaScript) or server-side processing that responds to events or data, which HTML alone cannot provide. So, without scripts or server logic, the page remains static, making the statement true. If you add JavaScript or server processing, the content can change dynamically.